| Dr Daniel Richard Weis, MD | |
|
1131 Manchester Ave, Middletown, OH 45042-1925 | |
| (513) 422-7016 | |
| (513) 422-5263 |
| Full Name | Dr Daniel Richard Weis |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 22 Years |
| Location | 1131 Manchester Ave, Middletown, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811967672 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 35.098730 (Ohio) | Primary |
| Entity Name | Butler Behavioral Health Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053377184 PECOS PAC ID: 9537061742 Enrollment ID: O20040127000062 |
News Archive
The Centers for Disease Control (CDC) and Prevention's National Center for Health Statistics (NCHS) released a report today, "Deaths: Preliminary Data for 2008," confirming that Chronic Obstructive Pulmonary Disease (COPD) became the third leading cause of death in the U.S. for 2008.
CyDex Pharmaceuticals, Inc. today announced that Prism Pharmaceuticals' NEXTERONE (amiodarone HCL) Premixed Injection, which recently received supplemental new drug application (sNDA) approval from the U.S. Food and Drug Administration, makes use of the patent-protected CyDex Captisol technology platform.
BerGenBio AS, an oncology biopharmaceutical company, announces that a paper entitled "Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine cross-talk of leukemia cells with bone marrow stroma" by Ben-Batalla et al., has been published in Blood, the most cited peer-reviewed research journal in the field of hematology.
It's usually used as livestock feed, but wheat bran's value in human nutrition and medicine may soon reach its full potential with a new sustainable processing method developed by Swedish researchers.
Kaiser Health News: "Proponents say that the legislation would spur competition among insurers and bring down costs for consumers. Reps. Tom Perriello, D-Va., and Betsy Markey, D-Colo., who are sponsoring the bill, said in a press release it would 'end special treatment for the insurance industry that allows them to fix prices, collude with each other, and set their own markets without fear of being investigated.' But many antitrust experts say that ending the exemption - by repealing the 1945 McCarran-Ferguson Act - wouldn't significantly increase competition or reduce premiums."
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Richard Weis, MD 1490 University Blvd, Hamilton, OH 45011-3305 Ph: (513) 881-7189 | Dr Daniel Richard Weis, MD 1131 Manchester Ave, Middletown, OH 45042-1925 Ph: (513) 422-7016 |
News Archive
The Centers for Disease Control (CDC) and Prevention's National Center for Health Statistics (NCHS) released a report today, "Deaths: Preliminary Data for 2008," confirming that Chronic Obstructive Pulmonary Disease (COPD) became the third leading cause of death in the U.S. for 2008.
CyDex Pharmaceuticals, Inc. today announced that Prism Pharmaceuticals' NEXTERONE (amiodarone HCL) Premixed Injection, which recently received supplemental new drug application (sNDA) approval from the U.S. Food and Drug Administration, makes use of the patent-protected CyDex Captisol technology platform.
BerGenBio AS, an oncology biopharmaceutical company, announces that a paper entitled "Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine cross-talk of leukemia cells with bone marrow stroma" by Ben-Batalla et al., has been published in Blood, the most cited peer-reviewed research journal in the field of hematology.
It's usually used as livestock feed, but wheat bran's value in human nutrition and medicine may soon reach its full potential with a new sustainable processing method developed by Swedish researchers.
Kaiser Health News: "Proponents say that the legislation would spur competition among insurers and bring down costs for consumers. Reps. Tom Perriello, D-Va., and Betsy Markey, D-Colo., who are sponsoring the bill, said in a press release it would 'end special treatment for the insurance industry that allows them to fix prices, collude with each other, and set their own markets without fear of being investigated.' But many antitrust experts say that ending the exemption - by repealing the 1945 McCarran-Ferguson Act - wouldn't significantly increase competition or reduce premiums."
› Verified 8 days ago
Dr. Marvin Baula, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4464 S Dixie Hwy, Middletown, OH 45005 Phone: 513-649-8008 | |
Andrea C Ribier, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 4464 S Dixie Hwy, Middletown, OH 45005 Phone: 513-649-8008 Fax: 513-649-8004 | |
Judith Ann Freeland, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 4464 S Dixie Hwy, Middletown, OH 45005 Phone: 513-649-8008 Fax: 513-649-8004 | |
Dr. Rachel Michelle Cash, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 4464 S Dixie Hwy, Department Of Psychiatry, Middletown, OH 45005 Phone: 513-649-8008 Fax: 513-649-8004 | |
Rokeya Tasnin, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4464 S Dixie Hwy, Middletown, OH 45005 Phone: 513-649-8008 Fax: 513-649-8004 | |
Percy David Mitchell Jr., MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1054 Summit Dr, Middletown, OH 45042 Phone: 513-727-1987 Fax: 513-727-0918 | |
Irfan Dahar, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 6730 Roosevelt Ave Ste 201, Middletown, OH 45005 Phone: 513-279-0857 |